Spyre Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Logos Global Management LP(0.4%),Logos Global Management GP LLC(0.4%), etc.

SEC · Feb 15 04:54

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.

Spyre Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Logos Global Management LP(0.4%),Logos Global Management GP LLC(0.4%), etc.

Risk Disclaimer